亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment

医学 队列 病态的 肿瘤科 胃肠病学 内科学 置信区间 食管切除术 诱导化疗 食管鳞状细胞癌 化疗 佐剂 食管癌 放化疗 外科 癌症
作者
Shao-Lun Lu,Feng‐Ming Hsu,Chiao‐Ling Tsai,Jang‐Ming Lee,Pei‐Ming Huang,Chih‐Hung Hsu,Chia‐Chi Lin,Yih‐Leong Chang,Min‐Shu Hsieh,Jason Chia‐Hsien Cheng
出处
期刊:Ejso [Elsevier BV]
卷期号:45 (8): 1498-1504 被引量:14
标识
DOI:10.1016/j.ejso.2019.03.020
摘要

Abstract Purpose To compare the locations of recurrences and survival outcomes in esophageal squamous cell carcinoma (ESCC) patients with pathological complete response (pCR) after neoadjuvant concurrent chemoradiotherapy (CCRT) with or without preceding induction chemotherapy (IC) followed by esophagectomy. Methods Among 276 patients with locally advanced ESCC undergoing trimodality treatment during 2004–2014, 94 (34.1%) with pCR were eligible. The cohort included 26 patients undergoing IC before CCRT (IC group), and 68 patients who did not receive IC (non-IC group). Results At a median follow-up of 51.4 months (95% confidence interval; 42.9–62.1), 19 patients experienced recurrences. There was a trend toward fewer distant failures in the IC group (0% vs.14.7%, p = 0.057), while locoregional recurrence was similar (7.7% vs. 7.4%). IC was associated with significantly improved survivals with the 5-year RFS and OS rates for the IC group of 85.1% and 90.5%, respectively, compared to of 46.2% and 48.1% for the non-IC group (p = 0.008 for RFS, and p = 0.015 for OS). By multivariable analyses, IC remained the only significant factor associated with survivals (HR:0.18 for RFS, p = 0.020 and HR:0.18 for OS, p = 0.025). The effect of IC in the whole cohort, irrespective of pathological response, was also assessed. Patients with non-pCR in the IC group had a trend toward worse survivals compared to the non-IC group Conclusions In ESCC patients with pCR after trimodality treatment, IC was associated with favorable survivals. The benefits of IC might be a hypothesis generation for adjuvant treatment for patients with pCR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
12秒前
小叶子完成签到 ,获得积分10
12秒前
Liufgui应助徐悦月采纳,获得10
14秒前
18秒前
Dave完成签到,获得积分10
33秒前
FashionBoy应助Dave采纳,获得10
36秒前
37秒前
38秒前
41秒前
顾矜应助Emon采纳,获得10
55秒前
1分钟前
1分钟前
芝麻完成签到,获得积分10
1分钟前
1分钟前
Dave发布了新的文献求助10
1分钟前
大模型应助芝麻采纳,获得10
1分钟前
1分钟前
jjjjj发布了新的文献求助10
1分钟前
Liufgui应助花凉采纳,获得20
1分钟前
biubiubiu发布了新的文献求助10
2分钟前
万能图书馆应助章鱼采纳,获得10
2分钟前
jjjjj完成签到,获得积分20
2分钟前
2分钟前
章鱼发布了新的文献求助10
2分钟前
牛八先生完成签到,获得积分10
2分钟前
2分钟前
孙燕应助jjjjj采纳,获得30
2分钟前
Liufgui应助花凉采纳,获得20
2分钟前
Ava关闭了Ava文献求助
2分钟前
科研通AI2S应助liudy采纳,获得10
2分钟前
科研通AI2S应助sljzhangbiao11采纳,获得10
2分钟前
2分钟前
徐悦月发布了新的文献求助10
2分钟前
三笠发布了新的文献求助10
2分钟前
小刘完成签到,获得积分10
3分钟前
3分钟前
三笠完成签到,获得积分10
3分钟前
传奇3应助Liiiiiiiiii采纳,获得10
3分钟前
gt完成签到 ,获得积分10
3分钟前
3分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990045
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256334
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805146
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228